Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EVFM | AZN | AMGN | GILD | VRTX |
| Company | Evofem Bioscience Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0092 | 194.22 | 375.05 | 147.11 | 497.88 |
| High | 0.0092 | 194.83 | 380.14 | 149.30 | 499.49 |
| Low | 0.0084 | 192.31 | 373.00 | 145.80 | 488.79 |
| Latest | 0.0087 | 193.31 | 377.64 | 146.00 | 492.38 |
| Change | -0.0002 | -1.68 | +2.21 | -2.56 | -6.79 |
| % Change | -2.25% | -0.86% | +0.59% | -1.72% | -1.36% |
| Volume | 40,400 | 1,416,800 | 2,300,000 | 5,552,100 | 2,062,700 |
| 20-Day Average Volume | 127,495 | 2,143,905 | 2,601,620 | 7,095,260 | 1,529,915 |
| Previous Close | 0.0089 | 194.99 | 375.43 | 148.56 | 499.17 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0091 | 202.88 | 376.43 | 149.34 | 477.40 |
| 20-Day Raw Stochastic | 36.36% | 16.95% | 54.94% | 22.25% | 72.86% |
| 20-Day Relative Strength | 44.70 | 47.21 | 57.13 | 53.31 | 56.13 |
| Weighted Alpha | -28.69 | +29.59 | +29.27 | +37.62 | +6.45 |
| Today's Opinion | 96% Sell | 64% Buy | 100% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 80% Buy | 88% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 80% Sell | 100% Buy | 100% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.40% since 03/04/26 | -4.08% since 03/04/26 | -0.43% since 03/04/26 | -1.50% since 03/04/26 | +3.03% since 03/04/26 |
| Low | 0.0083 on 03/06/26 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 0.0094 on 03/10/26 | 199.52 on 03/05/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 507.92 on 03/10/26 |
| 1-Month | |||||
| %Chg | -3.33% since 02/11/26 | -5.59% since 02/11/26 | +3.02% since 02/11/26 | -6.29% since 02/11/26 | +6.75% since 02/11/26 |
| Low | 0.0083 on 03/06/26 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 0.0094 on 03/10/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.95 on 02/13/26 | 507.92 on 03/10/26 |
| 3-Month | |||||
| %Chg | -33.08% since 12/11/25 | +7.05% since 12/11/25 | +18.99% since 12/11/25 | +18.50% since 12/11/25 | +10.42% since 12/11/25 |
| Low | 0.0069 on 01/20/26 | 178.08 on 01/21/26 | 315.19 on 12/12/25 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 0.0136 on 12/12/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| 6-Month | |||||
| %Chg | -16.35% since 09/11/25 | +19.18% since 09/11/25 | +33.57% since 09/11/25 | +23.88% since 09/11/25 | +23.91% since 09/11/25 |
| Low | 0.0069 on 01/20/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 0.0200 on 10/27/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,153 | 299,806,016 | 203,573,632 | 181,247,456 | 125,081,264 |
| Shares Outstanding, K | 132,530 | 1,550,908 | 539,068 | 1,241,421 | 254,034 |
| Annual Sales | 19,360,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -8,860,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 4,950,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | -1,570,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | -1.41 | 0.32 | 0.45 | 0.37 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 11/13/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 03/23/26 | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.29 | 17.18 | 18.23 | 30.40 |